Back to Search
Start Over
Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke
- Source :
- M2 Pharma. August 31, 2018
- Publication Year :
- 2018
-
Abstract
- M2 PHARMA-August 31, 2018-Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate Ryanodex for Exertional Heat Stroke (C)2018 M2 COMMUNICATIONS - US-based specialty pharmaceutical company [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.552505775